A screen for POLE mutations in a study of 251 Chinese samples of different subtypes of ovarian carcinomas, identified mutations in 3 out of 37 (8.1%) patients with ovarian endometrioid carcinoma, but not observed in the other subtypes42. This evidence concerns the gene POLE and ovarian carcinoma.